Cargando…
Psychiatric symptoms and cognitive impairment in “Long COVID”: the relevance of immunopsychiatry
Autor principal: | Penninx, Brenda W.J.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429338/ https://www.ncbi.nlm.nih.gov/pubmed/34505378 http://dx.doi.org/10.1002/wps.20913 |
Ejemplares similares
-
Immunopsychiatry after COVID-19
por: Benedetti, Francesco
Publicado: (2023) -
Immunopsychiatry: important facts
por: Khandaker, G. M., et al.
Publicado: (2017) -
Immunopsychiatry – Innovative Technology to Characterize Disease Activity in Autoantibody-Associated Psychiatric Diseases
por: Hansen, Niels
Publicado: (2022) -
Identifying causal role of COVID-19 in immunopsychiatry models
por: Horn, Sarah R., et al.
Publicado: (2020) -
The future of immunopsychiatry: Three milestones to clinical innovation
por: De Picker, L.J.
Publicado: (2021)